We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Olin Set to Expand Bleach Distribution With K2 Partnership
Read MoreHide Full Article
Key Takeaways
OLN partners with K2 to strengthen bleach distribution across California and the Western U.S. region.
The move aims to reduce railcar chlorine shipments by increasing local bleach production and supply.
Collaboration enhances safety, environmental responsibility, and customer service responsiveness.
Olin Corporation (OLN - Free Report) announced to strengthen its bleach distribution network across California and the Western United States in collaboration with K2. The partnership aims to improve supply chain continuity, increase geographical expanse and better its service responsiveness.
In a broader sense, the availability of bleach in this region will reduce the amount of railcar chlorine transported into the region. It is expected that more localized bleach will be produced and distributed, supporting the goals of safety, environmental responsibility, and supply chain resilience.
Olin’s market expertise and K2’s strength in regional production will ensure a safe and reliable supply to maintain public health. They will together set higher standards in the bleach production and distribution industry, ensuring optimum customer satisfaction.
For Q2 2025, OLN expects its Chemicals segment’s performance to remain steady despite higher costs from a delayed maintenance turnaround. The Winchester unit is projected to see improved results driven by seasonal demand and stronger military sales. Adjusted EBITDA is forecasted between $170 million and $210 million. Full-year 2025 capital expenditure is expected to range from $200 million to $220 million.
OLN stock has slumped 55.3% over the past year against the industry’s 18.6% decline.
The Zacks Consensus Estimate for NEM’s current-year earnings is pegged at $4.32 per share, indicating a 24.14% year-over-year increase.Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed once, with an average surprise of 32.41%. NEM’s shares have gained 42.7% in the past year.
The Zacks Consensus Estimate for Akzo Nobel’s current-year earnings is pegged at $1.69 per share, implying a 20.71% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters while missing once.
The Zacks Consensus Estimate for CF’s 2025 earnings is pegged at $6.83 per share, indicating a rise of 1.34% from year-ago levels. The company’s earnings beat the consensus estimate in each of the trailing four quarters. Its shares have gained 33% in the past year.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Olin Set to Expand Bleach Distribution With K2 Partnership
Key Takeaways
Olin Corporation (OLN - Free Report) announced to strengthen its bleach distribution network across California and the Western United States in collaboration with K2. The partnership aims to improve supply chain continuity, increase geographical expanse and better its service responsiveness.
In a broader sense, the availability of bleach in this region will reduce the amount of railcar chlorine transported into the region. It is expected that more localized bleach will be produced and distributed, supporting the goals of safety, environmental responsibility, and supply chain resilience.
Olin’s market expertise and K2’s strength in regional production will ensure a safe and reliable supply to maintain public health. They will together set higher standards in the bleach production and distribution industry, ensuring optimum customer satisfaction.
For Q2 2025, OLN expects its Chemicals segment’s performance to remain steady despite higher costs from a delayed maintenance turnaround. The Winchester unit is projected to see improved results driven by seasonal demand and stronger military sales. Adjusted EBITDA is forecasted between $170 million and $210 million. Full-year 2025 capital expenditure is expected to range from $200 million to $220 million.
OLN stock has slumped 55.3% over the past year against the industry’s 18.6% decline.
Image Source: Zacks Investment Research
OLN’s Zacks Rank & Key Picks
OLN currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Basic Materials space are Newmont Corporation (NEM - Free Report) , Akzo Nobel N.V. (AKZOY - Free Report) and CF Industries (CF - Free Report) . While NEM currently sports a Zacks Rank #1 (Strong Buy), AKZOY and CF carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for NEM’s current-year earnings is pegged at $4.32 per share, indicating a 24.14% year-over-year increase.Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed once, with an average surprise of 32.41%. NEM’s shares have gained 42.7% in the past year.
The Zacks Consensus Estimate for Akzo Nobel’s current-year earnings is pegged at $1.69 per share, implying a 20.71% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters while missing once.
The Zacks Consensus Estimate for CF’s 2025 earnings is pegged at $6.83 per share, indicating a rise of 1.34% from year-ago levels. The company’s earnings beat the consensus estimate in each of the trailing four quarters. Its shares have gained 33% in the past year.